echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > [Activated] The registration status of calcium hydrogen phosphate dihydrate is changed from "I" to "A"

    [Activated] The registration status of calcium hydrogen phosphate dihydrate is changed from "I" to "A"

    • Last Update: 2022-08-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Budenheim

    The registration number F20180000955 of calcium hydrogen phosphate dihydrate produced in Budenheim, Germany has now been activated, and the status has changed from "I" to ".


    Calcium hydrogen phosphate dihydrate

    Product Archives

    【Product】Calcium hydrogen phosphate dihydrate

    【Properties】White or off-white crystalline powder

    【Model】DI-CAFOS® D160, D14

    【Manufacturer】Budenheim

    【Registration number】F20180000955 has been activated

    【Standard】CP,USP,EP,JP

    【CAS .


    【Package specification】25KG/bag

    【Validity period】36 months

    【Performance】

    【Electron Microscope】

    D160 electron microscope 

    D14 electron microscope

    Product related tweets

    Calcium hydrogen phosphate dihydrate is mainly used as a diluent in preparations, and can also be used as a source of calcium in calcium supplemen.


    Tweet directly:

    D160, D14: Application and precautions of calcium hydrogen phosphate dihydrate (registration number has been announced)

    D160, T500, A60, A150: Application of calcium phosphate salt in direct pressing process

    D160, A60: Study on the stability of acetylsalicylic acid in formulations containing different excipients under different storage conditions

    Application examples

    sample application

    Budenheim, Germany is a global professional chemical company founded in 190 In 1916, it first invented the production of calcium phosphate by high-pressure process reacti.


    Scan QR code to apply for samples
    special offer
    Focus on new functional pharmaceutical excipients!
    25 original content

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.